RARA CRAFT DATABASE for FDA Medical Devices
510(k)K254198

FDA DEVICE FACTS

Trexo Theo

Trexo Robotics, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATESeptember 2, 2026PRODUCT CODEPHL

Indications for use

The subject device is a powered lower-limb exoskeleton intended to perform ambulatory functions in individuals with cerebral palsy who are 12 years and up, under supervision in both clinic and community environments. The primary predicate, HAL-ML, is a powered exoskeleton indicated for improved ambulation in individuals with neuromuscular conditions including cerebral palsy, in rehabilitation and clinical environments under trained supervision. The Trexo device is indicated for use in a subset of the patient population cleared for HAL-ML and supports similar ambulatory functions, including standing and level-ground walking. The secondary predicate, Rewalk, is a powered exoskeleton indicated to perform ambulatory functions in home and community environments under supervision of trained companions. The Trexo device similarly supports supervised assisted ambulation outside of clinical environments. Across the subject and predicate devices, the indications of use are limited to powered assistance for ambulation. Trexo has submitted clinical data to support the safety and effectiveness of the device used in the different intended settings.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: October 7, 2026